Sabo bill assessed

Proposed US open-access law could create more problems than it solves, critics warn

Written byCatherine Zandonella
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A bill that would ban copyright on journal articles and other write-ups of federally funded scientific research could have numerous unintended consequences, critics say. Even those who agree with the bill's intent—to promote open access to scientific literature—fear the proposed legislation could backfire.

The bill is a "well intentioned but perhaps overly simple solution to a very complex problem," said Jerome H. Reichman, a professor at the Duke University School of Law who serves as a consultant on intellectual property rights to the US National Academy of Sciences.

Perhaps the biggest danger posed by the bill, Reichman said, is that scientists' control over their published works may be eroded further than it already is under the current scientific publishing model.

Introduced 3 weeks ago by Rep. Martin Sabo (D-Minn.), the bill prohibits copyright protection for works produced from research substantially funded by the Federal Government.

Under current federal law, authors ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies